The historical rank and industry rank for RBC Life Sciences's Gross Margin % or its related term are showing as below:
RBCL's Gross Margin % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 26.37 * Ranked among companies with meaningful Gross Margin % only.
RBC Life Sciences had a gross margin of 56.45% for the quarter that ended in Jun. 2017 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for RBC Life Sciences was 0.00% per year.
RBC Life Sciences (OTCPK:RBCL) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
RBC Life Sciences had a gross margin of 56.45% for the quarter that ended in Jun. 2017 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
RBC Life Sciences Gross Margin % Related Terms
RBC Life Sciences Gross Margin % Historical Data
* Premium members only.
The historical data trend for RBC Life Sciences's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RBCL vs SKVI, TISUQ, TECR: Gross Margin % Comparison
For the Household & Personal Products subindustry, RBC Life Sciences's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RBC Life Sciences Gross Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Gross Margin % distribution charts can be found below:
* The bar in red indicates where RBC Life Sciences's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
RBC Life Sciences (RBCL) has a Gross Margin % of 56.45% as of Jun. 2017. Gross margin is the ratio of total gross profit to net sales. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Gross Margin % too high?
RBC Life Sciences' current Gross Margin % is 56.45%. The Consumer Packaged Goods industry median Gross Margin % is 26.37. RBC Life Sciences' value of 56.45% is 114.1% above this industry median.
How does RBC Life Sciences' Gross Margin % compare to SKVI and TISUQ?
RBC Life Sciences' Gross Margin % of 56.45% can be compared against companies in the Consumer Packaged Goods industry. The industry median Gross Margin % is 26.37. RBC Life Sciences' value of 56.45% is 114.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Consumer Packaged Goods company?
The median Gross Margin % among Consumer Packaged Goods companies is 26.37, based on 1,902 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RBC Life Sciences's current Gross Margin % of 56.45% is 114.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on RBC Life Sciences and its competitors. For the Consumer Packaged Goods industry, the median Gross Margin % is 26.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RBC Life Sciences's current Gross Margin % is 56.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Gross Margin % of 56.45%. The current Gross Margin % is 56.45% and 114.1% above the Consumer Packaged Goods industry median of 26.37. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Gross Margin % is 56.45% as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RBCL has been successfully added to your 